World's Best Scientists 2026 revealed!
Johannes Kornhuber

Johannes Kornhuber

D-Index & Metrics

Medicine

D-Index
123
Citations
70246
World Ranking
3298
National Ranking
178

Overview

Johannes Kornhuber is affiliated with the University of Göttingen in Germany and has contributed extensively to research in medicine, neuroscience, and biochemistry, genetics, and molecular biology. Their work spans several subfields, including molecular biology, psychiatry and mental health, physiology, neurology, and clinical psychology.

Their research output covers a wide range of topics, with a focus on sphingolipid metabolism and signaling, dementia and cognitive impairment research, and Alzheimer's disease research and treatments. Other main topics include tryptophan and brain disorders, receptor mechanisms and signaling, neuroendocrine regulation and behavior, as well as stress responses and cortisol.

Johannes Kornhuber's frequent co-authors include:

  • Christiane Mühle
  • Bernd Lenz
  • Erich Gulbins
  • Jens Wiltfang
  • Christian P. Müller

The venues where they have published most frequently are:

  • International Journal of Molecular Sciences (15 publications)
  • Alzheimer's & Dementia (9 publications)
  • Molecular Psychiatry (8 publications)
  • Journal of Neural Transmission (8 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (8 publications)

Some of their recent papers include:

  • "Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum," 2022, JAMA Neurology
  • "Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells," 2020, Cell Reports Medicine
  • "Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers," 2022, Acta Neuropathologica
  • "The acid sphingomyelinase/ceramide system in COVID-19," 2021, Molecular Psychiatry
  • "Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression," 2021, Alzheimer's Research & Therapy

Best Publications

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

    Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

  • Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (Nature Genetics (2009) 41 (1088-1093))

    D Harold;R Abraham;P Hollingworth;R Sims

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

    Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold

  • Therapeutic approaches to Alzheimer's disease.

    Hans-Wolfgang Klafki;Matthias Staufenbiel;Johannes Kornhuber;Jens Wiltfang

  • Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs

    Erich Gulbins;Erich Gulbins;Monica Palmada;Martin Reichel;Anja Lüth

  • Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents : Preclinical studies

    W. Danysz;C.G. Parsons;J. Kornhuber;W.J. Schmidt

  • Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

    Markus Otto;Jens Wiltfang;Hayrettin Tumani;Inga Zerr

  • BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation.

    T. Kraus;K. Hösl;O. Kiess;A. Schanze

  • Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

    Kornhuber J;Weller M;Schoppmeyer K;Riederer P

  • Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

    Stephanie J B Vos;Frans Verhey;Lutz Frölich;Johannes Kornhuber

  • Neurochemical diagnosis of Alzheimer’s dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

    Piotr Lewczuk;Hermann Esselmann;Markus Otto;Juan Manuel Maler

  • Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

    Johannes Kornhuber;Joachim Bormann;Marianne Hübers;Kristin Rusche

  • Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.

    Johannes Kornhuber;Philipp Tripal;Martin Reichel;Christiane Mühle

  • Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.

    Johannes Kornhuber;Joachim Bormann;Wolfgang Retz;Marianne Hübers

  • Memantine in moderate-to-severe Alzheimer's disease.

    Stefan Bleich;Jens Wiltfang;Johannes Kornhuber

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimertextquotesingles disease

    Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

Frequent Co-Authors

Jens Wiltfang
Jens Wiltfang University of Göttingen
Frank Jessen
Frank Jessen University of Cologne
Oliver Peters
Oliver Peters German Center for Neurodegenerative Diseases
Erich Gulbins
Erich Gulbins University of Duisburg-Essen
Wolfgang Maier
Wolfgang Maier University of Bonn
Lutz Frölich
Lutz Frölich Heidelberg University
Harald Hampel
Harald Hampel Eisai (United States)
Michael Wagner
Michael Wagner TU Dresden
Peter Riederer
Peter Riederer University of Würzburg
Hermann Esselmann
Hermann Esselmann University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if medical school is the only path? There are many online degree programs that open doors to rewarding careers in medicine and beyond. For those passionate about food and wellness, online nutrition degree programs can prepare you for roles in dietetics, public health, wellness coaching, and health education.

If you see yourself working in leadership roles within hospitals or clinics, consider exploring which online healthcare administration programs have CAHME accreditation? CAHME-accredited programs ensure high standards, making you more competitive for management and executive positions in healthcare organizations.

For registered nurses aiming to advance quickly, there are unique RN to BSN with no clinicals options. These accelerated programs help current RNs earn their bachelor’s degree efficiently and with added flexibility—particularly useful for working professionals.

Finally, if you aspire to the highest levels of nursing practice, explore short DNP programs online. These Doctor of Nursing Practice tracks can be completed faster, empowering you to step into leadership or advanced practice roles sooner.

Best Scientists Citing Johannes Kornhuber

Trending Scientists

Recently Published Articles